AstraZeneca boss Sir Pascal Soriot (pictured) is thought to be mulling shifting its listing to New York due to growing frustration about UK rules.Read More
You might also be interested in reading Trump is said to weigh $10B farm aid plan amid tariff fallout, trade tensions.